Showing results (561-570 of 677) with videos related to
Sort By:
Pageof 68
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reasonGiammarco Mocci, Arianna Cingolani, Giorgia Orrù, et al.Journal of Clinical Medicine|June 13, 2025
Clinical and Genetic Characteristics of Pediatric Patients with Inflammatory Bowel Disease Transitioning to Adult Medicine: A Single-Center Ten-Year ExperienceGiammarco Mocci, Giorgia Orrù, Francesca Maria Onidi, et al.The Journal of Rheumatology|February 9, 2018
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel DiseaseMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.Head & Neck|April 20, 2022
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic reviewGiuditta Mannelli, Lara V Comini, Andrea Sacchetto, et al.Scientific Reports|April 1, 2017
Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's diseaseIsabel Gameiro, Patrycja Michalska, Giammarco Tenti, et al.Patient Preference and Adherence|July 15, 2026
Patient Knowledge and Adherence to Oral Anticoagulation Therapy: Findings from an Observational Study in Italian Tertiary Care HospitalsManuela Stella, Davide Boccardi, Giammarco Baiardi, et al.European Journal of Internal Medicine|May 4, 2019
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Devis Benfaremo, Emanuele Bendia, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 26, 2019
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcomeGiuseppe Tarantino, Alessio Ortolani, Katia Marinelli, et al.American Journal of Physiology. Cell Physiology|January 29, 2011
Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasionSharon DeMorrow, Paolo Onori, Julie Venter, et al.Journal of Personalized Medicine|November 27, 2021
Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant TemozolomideFabiana Gregucci, Alessia Surgo, Ilaria Bonaparte, et al.Pageof 68